FMC downgraded at RBC Capital
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Moody’s (MCO – Research Report) on February 4 and set a price target of $550.00.
RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...
RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...
RBC Capital analyst Ashish Sabadra maintained a Buy rating on S&P Global (SPGI – Research Report) on February 4 and set a price target of ...
RBC Capital Markets adjusted its outlook on Atkore International Group Inc . (NYSE: NYSE:ATKR), reducing the company's price target from $91.00 to $73.00 while maintaining a Sector Perform rating.
Acknowledging that there is skepticism surrounding its business model and ability to sustain profitability targets, RBC Capital joins the growing list of bulls in support of Carvana, raising its ...
J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
analysts at RBC Capital Markets said. The tweak to the required acceptance threshold for the bid, which now excludes shares held in treasury with no voting rights, came “at the request of the ...
RBC Capital keeps an Outperform rating and $235 price target on Alphabet (GOOGL) after its Q4 results. The quarter keeps the AI Search bear ...
Investing.com -- RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270. According to the firm’s analysts, following ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback